(Q82668142)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19020547%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

Favorable prognostic impact of NPM1 gene mutations in childhood acute myeloid leukemia, with emphasis on cytogenetically normal AML (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19020547%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

main subject

acute myeloid leukemia

1 reference

childhood acute myeloid leukemia

inferred from title

1 reference

13

C Thiede

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19020547%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

I H I M Hollink

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19020547%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

C M Zwaan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19020547%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

M Zimmermann

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19020547%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

T C J M Arentsen-Peters

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19020547%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

R Pieters

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19020547%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

J Cloos

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19020547%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

G J L Kaspers

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19020547%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

S S N de Graaf

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19020547%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

J Harbott

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19020547%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

U Creutzig

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19020547%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

D Reinhardt

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19020547%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

M M van den Heuvel-Eibrink

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19020547%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

publication date

20 November 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19020547%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19020547%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19020547%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19020547%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

262-270

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19020547%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/leu.2008.313

17 January 2020

exact match

0 references

cites work

Major nucleolar proteins shuttle between nucleus and cytoplasm

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.313

7 January 2021

Nucleophosmin regulates the stability and transcriptional activity of p53

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.313

7 January 2021

ARF impedes NPM/B23 shuttling in an Mdm2-sensitive tumor suppressor pathway

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.313

7 January 2021

Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.313

7 January 2021

Both carboxy-terminus NES motif and mutated tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+ AML.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.313

7 January 2021

Cytoplasmic localization of NPM in myeloid leukemias is dictated by gain-of-function mutations that create a functional nuclear export signal.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.313

7 January 2021

Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML).

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.313

7 January 2021

Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML): association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.313

7 January 2021

Nucleophosmin mutations in de novo acute myeloid leukemia: the age-dependent incidences and the stability during disease evolution

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.313

7 January 2021

Clinical characteristics and prognostic implications of NPM1 mutations in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.313

7 January 2021

Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.313

7 January 2021

Prevalence, clinical profile, and prognosis of NPM mutations in AML with normal karyotype

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.313

7 January 2021

Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.313

7 January 2021

Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification?

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.313

7 January 2021

Childhood and adolescent lymphoid and myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.313

7 January 2021

Nucleophosmin mutations in childhood acute myelogenous leukemia with normal karyotype

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.313

7 January 2021

The incidence and clinical significance of nucleophosmin mutations in childhood AML.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.313

7 January 2021

No nucleophosmin mutations in pediatric acute myeloid leukemia with normal karyotype: a study of the Japanese Childhood AML Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.313

7 January 2021

Different types of NPM1 mutations in children and adults: evidence for an effect of patient age on the prevalence of the TCTG-tandem duplication in NPM1-exon 12

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.313

7 January 2021

Mononuclear cells contaminating acute lymphoblastic leukaemic samples tested for cellular drug resistance using the methyl-thiazol-tetrazolium assay

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.313

7 January 2021

Treatment strategy and results in children treated on three Dutch Childhood Oncology Group acute myeloid leukemia trials.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.313

7 January 2021

Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trials

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.313

7 January 2021

Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trials

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.313

7 January 2021

Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.313

7 January 2021

Stability and prognostic influence of FLT3 mutations in paired initial and relapsed AML samples

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.313

7 January 2021

Targeting FLT3 in primary MLL-gene-rearranged infant acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.313

7 January 2021

Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML): biologic and clinical features

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.313

7 January 2021

Differences in the prevalence of PTPN11 mutations in FAB M5 paediatric acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.313

7 January 2021

FLT3 internal tandem duplication in 234 children with acute myeloid leukemia: prognostic significance and relation to cellular drug resistance

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.313

7 January 2021

The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.313

7 January 2021